Percutaneous Electrical Nerve Stimulation in Children with Therapy Resistant Nonneuropathic Bladder Sphincter Dysfunction: a Pilot Study
Overview
Affiliations
Purpose: We evaluated the effect of percutaneous electrical nerve stimulation on voiding dysfunction in a group of children with therapy resistant, nonneuropathic bladder sphincter dysfunction.
Materials And Methods: In a prospective study 17 boys and 15 girls with mean age of 11.7 years underwent percutaneous electrical nerve stimulation after the failure of more than 2 years of urological and/or pharmacotherapy. The device for percutaneous electrical nerve stimulation consists of an interface cable, a surface electrode, a percutaneous needle and a portable stimulator. The needle is inserted at the tibial nerve level and a portable stimulator provided pulsations at a frequency of 20 Hz. for 30 minutes once weekly. Every 6 weeks the children were evaluated. Evaluation parameters were urgency, daytime incontinence, voiding frequency, the uroflowmetry curve and bladder capacity. When favorable results were observed after 6 sessions, therapy was continued for another 12 sessions. In 24 children anticholinergics started before stimulation that had only a partial effect were continued during stimulation.
Results: In 7 of the 28 children with urgency before therapy it disappeared after therapy and in 10 it improved. Of the 23 children with daytime incontinence before treatment 4 became dry after stimulation and in 12 incontinence decreased. Of the 19 patients who reported disturbed voiding frequency of less than 4 or more than 8 voids daily 16 achieved a normal frequency of 4 to 6 voids daily. In 21 children an abnormal uroflowmetry curve was observed before stimulation, while in 9 the flow curve was normal after therapy. Mean bladder capacity increased significantly from 185.16 to 279.19 ml.
Conclusions: Percutaneous electrical nerve stimulation has a significant effect on voiding frequency, the uroflowmetry curve and bladder capacity in children with nonneurogenic bladder sphincter dysfunction
Abdelghany M, Amar M, Shoukry A, Morsi H, Mohamed H Arab J Urol. 2024; 22(4):268-273.
PMID: 39355791 PMC: 11441059. DOI: 10.1080/20905998.2024.2373404.
Third-Line Therapeutic Interventions for Non-Neurogenic Bladder Dysfunction in Children.
Lombardo A, Alpert S Curr Urol Rep. 2024; 25(12):331-338.
PMID: 39093503 DOI: 10.1007/s11934-024-01227-3.
Kirli E, Turk S, Kirli S Alpha Psychiatry. 2022; 22(1):43-48.
PMID: 36426208 PMC: 9590664. DOI: 10.5455/apd.119660.
Qiu S, Bi S, Lin T, Wu Z, Jiang Q, Geng J Asian J Urol. 2019; 6(4):330-338.
PMID: 31768318 PMC: 6872791. DOI: 10.1016/j.ajur.2019.04.001.
Thomas D, Yener S, Kalyoncu A, Uluc K, Bayri Y, Dagcinar A Childs Nerv Syst. 2017; 33(8):1327-1333.
PMID: 28342118 DOI: 10.1007/s00381-017-3393-2.